Showing results (681-690 of 737) with videos related to

Sort By:
Pageof 74
Trials|March 19, 2023
Core protocol for the adaptive Platform Trial In COVID-19 Vaccine priming and BOOsting (PICOBOO)C McLeod, J Ramsay, K L Flanagan, et al.
International Journal of Cancer|June 9, 2023
Efficacy and safety of lenvatinib plus pembrolizumab vs sunitinib in the East Asian subset of patients with advanced renal cell carcinoma from the CLEAR trialSun Young Rha, Toni K Choueiri, Vsevolod B Matveev, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2005
Furanyl-1,3-thiazol-2-yl and benzoxazol-5-yl acetic acid derivatives: novel classes of heparanase inhibitorStephen M Courtney, Philip A Hay, Richard T Buck, et al.
British Journal of Anaesthesia|October 21, 2010
Obstructive sleep apnoea and perioperative complications in bariatric patientsT N Weingarten, A S Flores, J A McKenzie, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 18, 2020
Adiposity, Physical Function, and Their Associations With Insulin Resistance, Inflammation, and Adipokines in CKDSankar D Navaneethan, John P Kirwan, Erick M Remer, et al.
Nature Communications|May 30, 2019
The major secreted protein of the whipworm parasite tethers to matrix and inhibits interleukin-13 functionAllison J Bancroft, Colin W Levy, Thomas A Jowitt, et al.
The Journal of Infection|September 28, 2024
The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-<70 years oldC McLeod, M Dymock, K L Flanagan, et al.
Journal for Immunotherapy of Cancer|February 16, 2021
Integrating genome-wide CRISPR immune screen with multi-omic clinical data reveals distinct classes of tumor intrinsic immune regulatorsJiakai Hou, Yunfei Wang, Leilei Shi, et al.
The Journal of Trauma and Acute Care Surgery|October 20, 2025
Analysis of preventable transfers from Montana to out-of-state pediatric trauma centers: A multicenter collaborationAbigail J Alexander, Christopher Clinker, Jack Scaife, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2019
Anti-OX40 Antibody Directly Enhances The Function of Tumor-Reactive CD8+ T Cells and Synergizes with PI3Kβ Inhibition in PTEN Loss MelanomaWeiyi Peng, Leila J Williams, Chunyu Xu, et al.
Pageof 74